Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ultra Nasdaq Biotech Proshares (BIB)

Ultra Nasdaq Biotech Proshares (BIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family ProShares
  • Assets Under Management 244,369,800
  • Shares Outstanding, K 2,650
  • 60-Month Beta 2.18
Trade BIB with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.00
  • Most Recent Dividend 0.088
  • Management Fee 0.95%
  • Sectors:

Options Overview

Details
  • Implied Volatility 63.24%
  • Historical Volatility 42.90%
  • IV Percentile 77%
  • IV Rank 13.07%
  • IV High 204.01% on 03/16/20
  • IV Low 42.07% on 12/03/20
  • Put/Call Vol Ratio 0.45
  • Today's Volume 77
  • Volume Avg (30-Day) 177
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 918
  • Open Int (30-Day) 1,024

Price Performance

See More
Period Period Low Period High Performance
1-Month
88.58 +3.71%
on 02/26/21
113.06 -18.74%
on 02/10/21
-9.98 (-9.80%)
since 01/26/21
3-Month
73.94 +24.25%
on 11/27/20
113.06 -18.74%
on 02/10/21
+18.95 (+25.99%)
since 11/25/20
52-Week
35.49 +158.83%
on 03/18/20
113.06 -18.74%
on 02/10/21
+32.91 (+55.82%)
since 02/26/20

Most Recent Stories

More News
4 Best-Performing Leveraged ETF Areas of Last Week

Last week witnessed a tug-of-war between bulls and bears.

MSFT : 232.38 (+1.48%)
SPY : 380.36 (-0.52%)
QQQ : 314.14 (+0.42%)
BIB : 91.87 (-0.55%)
DIA : 309.45 (-1.44%)
CWEB : 80.69 (-1.60%)
TQQQ : 89.22 (+1.50%)
TECL : 402.39 (+1.61%)
PILL : 26.75 (-2.59%)
CURE : 74.51 (-2.72%)
NEED : 32.19 (+0.11%)
FNGU : 33.89 (+0.06%)
FNGO : 42.27 (-0.09%)
WEB : 27.99 (unch)
Biotech ETFs in Focus on String of Q1 Earnings Beats

Let's take a sneak peek at some ETFs having high exposure to some impactful biotechnological companies on the release of Q1 earnings results.

FBT : 168.20 (-0.15%)
BBH : 179.00 (+0.26%)
IBB : 156.93 (-0.14%)
BIB : 91.87 (-0.55%)
BIIB : 272.88 (-1.58%)
AMGN : 224.92 (-1.14%)
ALXN : 152.75 (-0.59%)
GILD : 61.40 (-2.21%)
Biotech ETFs in Focus on String of Q1 Earnings Beats

Let's take a sneak peek at some ETFs having high exposure to some impactful biotechnological companies on the release of Q1 earnings results.

FBT : 168.20 (-0.15%)
BBH : 179.00 (+0.26%)
IBB : 156.93 (-0.14%)
BIB : 91.87 (-0.55%)
BIIB : 272.88 (-1.58%)
AMGN : 224.92 (-1.14%)
ALXN : 152.75 (-0.59%)
GILD : 61.40 (-2.21%)
Will Biotech ETFs Continue to Rally in Q1 Earnings?

Here we study the possible impact of some major Q1 earnings releases on certain biotech ETFs .

FBT : 168.20 (-0.15%)
BBH : 179.00 (+0.26%)
BIB : 91.87 (-0.55%)
IBB : 156.93 (-0.14%)
GILD : 61.40 (-2.21%)
ALXN : 152.75 (-0.59%)
AMGN : 224.92 (-1.14%)
Will Biotech ETFs Continue to Rally in Q1 Earnings?

Here we study the possible impact of some major Q1 earnings releases on certain biotech ETFs .

FBT : 168.20 (-0.15%)
BBH : 179.00 (+0.26%)
BIB : 91.87 (-0.55%)
IBB : 156.93 (-0.14%)
GILD : 61.40 (-2.21%)
ALXN : 152.75 (-0.59%)
AMGN : 224.92 (-1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the NASDAQ Biotechnology Index.

See More

Top 10 Holdings

Name % Holdings
ProShares Ultra Nasdaq Biotechnology ETF 0.00%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 0.00%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 0.00%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 0.00%
ISHARES BIOTECH (IBB) SWAP GOLDMAN SACHS INTERNATIONAL 0.00%
ISHARES BIOTECH (IBB) SWAP BANK OF AMERICA NA 0.00%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 0.00%
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 0.00%
NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 0.00%
ISHARES BIOTECH (IBB) SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 0.00%

See More

Key Turning Points

3rd Resistance Point 100.52
2nd Resistance Point 97.48
1st Resistance Point 94.67
Last Price 91.87
1st Support Level 88.82
2nd Support Level 85.78
3rd Support Level 82.97

See More

52-Week High 113.06
Last Price 91.87
Fibonacci 61.8% 83.43
Fibonacci 50% 74.28
Fibonacci 38.2% 65.12
52-Week Low 35.49

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar